SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long term, according to a study from the UK and Ireland.

Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular ...

Health insurance status significantly impacts access to psoriasis care, with public-only and uninsured patients facing ...

For walkers and runners, plantar fasciitis is a painful and frustrating injury. Learn how to prevent and treat the condition ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

D ryness, redness, and irritation are the most widespread winter skin woes, but anyone who struggles with skin conditions ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

Research analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note ...